Librea, Nimfa E.
HRN: 21-44-55 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2023
CEFTRIAXONE 1G (VIAL)
05/09/2023
05/16/2023
IV
2gm
OD
Breast Mass
Waiting Final Action